Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

IBBvsIVV

iShares Biotechnology ETF against iShares Core S&P 500 ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
IBB 126IVV 111Nov 25Nov 26GROWTH OF $100
Head to head
IBBIVV
Expense ratio0.44%0.030%
Assets$11.1B$879.1B
Net flow, 1 month−$73M+$10.1B
Net flow, 1 year+$1.2B+$71.4B
Return, YTD+23.2%+8.5%
Return, 1 year——
Avg daily volume2M5.5M
Holdings243505
ListedFeb 5, 2001May 15, 2000
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.